As of May 31, 2025, Canopy Growth Corp (WEED.TO) reports a Net Margin of -221.19%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Canopy Growth Corp's Net Margin
Over recent years, Canopy Growth Corp's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-03-31 | -221.19% |
| 2023-03-31 | -813.65% |
| 2022-03-31 | -60.75% |
| 2021-03-31 | -319.23% |
| 2020-03-31 | -331.32% |
This slight upward trend highlights how Canopy Growth Corp manages its overall profitability and cost control over time.
Comparing Canopy Growth Corp's Net Margin to Peers
To better understand Canopy Growth Corp's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Canopy Growth Corp (WEED.TO) | -221.19% |
| Cronos Group Inc (CRON.TO) | 34.93% |
| Amphastar Pharmaceuticals Inc (AMPH) | 21.79% |
| Corcept Therapeutics Inc (CORT) | 20.92% |
| Harmony Biosciences Holdings Inc (HRMY) | 20.36% |
| Horizon Therapeutics PLC (HZNP) | 14.37% |
Compared to its competitors, Canopy Growth Corp's Net Margin is among the lowest compared to peers, which may indicate challenges in controlling expenses or competitive pricing pressures.